A Study to Evaluate Long-term Safety of Ecopipam Tablets in Children, Adolescents and Adults With Tourette's Disorder

PHASE3Active, not recruitingINTERVENTIONAL
Enrollment

150

Participants

Timeline

Start Date

August 16, 2023

Primary Completion Date

December 31, 2026

Study Completion Date

March 31, 2027

Conditions
Tourette Syndrome
Interventions
DRUG

Ecopipam

Selective dopamine D1 and D5 receptor antagonist

Trial Locations (67)

165

Ospedale Pediatrico Bambino Ges, Roma

1100

Clinic of Neurology and Psychiatry for Children and Adolescents, Belgrade

1146

Bethesda Childrens Hospital(Magyarországi Református Egyház Bethesda Gyermekkórháza), Budapest

1360

ASMP-IP- d-r Kayryakova, Sofia

1680

Kalimat Medical Center_Sofia, Sofia

4004

Center Spectar-Plovdiv, Plovdiv

6720

Szegedi Tudomanyegyetem Altalanos Orvostudomanyi Kar Gyermek-es Ifjusagpszicihatria, Szeged

11120

Institute of Mental Health, Belgrade

14642

University of Rochester, Rochester

16148

Istituto Giannina Gaslini, Universita di Genova, Genova

18000

Clinical Centre Nis Center of Mental Health, Niš

20010

Childrens National Hospital, Washington D.C.

20133

IRCCS Istituto Neurologico Carlo Besta, Milan

21205

Kennedy Krieger Institute, Baltimore

28007

Hospital General Universitario Gregorio Maranon, Madrid

28041

Hospital Universitario 12 de Octubre, Madrid

28211

OnSite Clinical Solutions LLC, Charlotte

29414

Coastal Pediatric Research, Charleston

30329

Rare Disease Research, LLC, Atlanta

32561

NW FL Clinical Research Group, LLC, Gulf Breeze

32763

Medical Research Group of Central Florida, Orange City

32803

APG Research, LLC, Orlando

33011

Hospital Universitario Central de Asturias, Oviedo

33136

University of Miami Miller School of Medicine, Miami

33173

Florida International Research Center, Miami

33609

Pediatric Epilepsy and Neurology Specialists, Tampa

33701

University of South Florida, St. Petersburg

36303

Harmonex, Inc., Dothan

37203

Access Clinical Trials, Inc., Nashville

40202

University of Louisville Research Foundation Inc., Louisville

41013

Hospital Universitario Virgen del Rocío, Seville

43205

National Childrens Hospital - The Ohio State University, Columbus

44130

North Star Medical Research, LLC, Middleburg Heights

45229

Cincinnati Children's Hospital Medical Center, Cincinnati

46256

Josephson-Wallack-Munshower Neurology, Indianapolis

48105

Michigan Clinical research Institute PC, Ann Arbor

48302

Neurobahavioral Medicine Group, Bloomfield Hills

60611

Lurie Children Hospital of Chicago, Chicago

60612

Rush University Medical Center, Chicago

63110

St. Louis Children's Hospital, St Louis

68526

Alivation Research, Lincoln

72202

Arkansas Children's Hospital, Little Rock

75390

UT Southwestern, Dallas

77030

The University of Texas Health Science Center at Houston, Houston

78249

Road Runner Research, Ltd, San Antonio

80131

Universita degli Studi di Napoli Federico II, Napoli

84020

Cedar Clinical Research, Draper

90706

CenExel CIT-IE, Bellflower

91203

Cortica Site Network, Glendale

92805

Advanced Research Center, Anaheim

94903

Cortica Site Network - San Rafael, San Rafael

95123

"Azienda Ospedaliero Universitaria G. Rodolico - San Marco", Catania

97225

Providence Brain and Spine Institute, Portland

98201

Core Clinical Research, Everett

06519

Yale School of Medicine, New Haven

33013-3834

Research in Miami Inc, Hialeah

02114

Mass General Hospital, Boston

02115

Boston Childrens Hospital, Boston

01655

Umass Chan Medical School, Worcester

37203-6502

Access Clinical Trials, Inc., Nashville

37232-2551

Vanderbilt University Medical Center, Nashville

L1Z 0M1

The Kids Clinic Inc, Ajax

40-689

Neurologia Śląska Centrum Medyczne, Katowice

80-542

Gdanskie Centrum Zdrowia Sp z o.o., Gdansk

61-731

Clinical Research Center Sp. z o.o. MEDIC-R Sp.k., Poznan

31-503

Wojewdzki Specjalistyczny Szpital Dziecicy im. sw. Ludwika w Krakowie, Krakow

30-363

Centrum Medyczne Plejady, Krakow

Sponsors
All Listed Sponsors
lead

Emalex Biosciences Inc.

INDUSTRY